Hosted on MSN

Recursion Pharmaceuticals projects $100M synergies in 2025 amid advancing pipeline and partnerships

CEO Chris Gibson highlighted significant progress in 2024, including clinical data readouts from REC-617 and REC-994, which showed early efficacy signals and robust safety, respectively. REC-617, a ...
CNET

Are You Using ChatGPT? Avoid These 11 Tasks

Artificial Intelligence is everywhere, from shopping assistants on Amazon, to replacing search engines like Google. While ChatGPT might make it easy to put together a shopping list or travel plans, it ...